eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by eHealth, Inc. on August 29, 2019, reporting events that occurred on August 28, 2019. The filing addresses corporate governance changes specifically regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
The primary material change reported is the appointment of Beth A. Brooke as a Class II director. Ms. Brooke brings significant experience in public policy, having served as the global vice chair of public policy for EY (formerly Ernst & Young) from 2007 to June 2019. She also previously served in the U.S. Department of the Treasury during the Clinton administration.
Compensatory Arrangements and Governance
- Director Appointment: Beth A. Brooke was appointed as a non-employee director.
- Equity Grant: In connection with her appointment, Ms. Brooke received an automatic grant of 1,460 restricted stock units (RSUs) under the Company's 2014 Equity Incentive Plan.
- Vesting Schedule: The RSUs vest annually over four years from the date of grant.
- Committee Assignments: The Board has not yet determined the specific committee(s) to which Ms. Brooke will be named.
- Related Party Transactions: No transactions requiring disclosure under Item 404(a) of Regulation S-K exist between Ms. Brooke or her immediate family and the Company.
Investor Verification Checklist
- Verify the vesting schedule and performance conditions (if any) for the 1,460 RSUs granted to the new director.
- Monitor future filings for the announcement of Ms. Brooke's specific Board committee assignments.
- Review the Company's 2014 Equity Incentive Plan to understand the total pool of shares available for future grants.